Watch for the pricing and closing of the offering in the next 1-2 days. The company's ability to raise capital at all will signal near-term survival; the size and terms will determine the dilution magnitude. Given the going concern risk and Nasdaq compliance issues, any offering is likely to be deeply dilutive.
Price Chart
Executive Summary
The SEC declared effective NewGenIvf Group Ltd's F-1 registration statement (File No. 333-298442) on September 28, 2026, allowing the company to proceed with its proposed best-efforts offering of Class A Ordinary Shares and Pre-Funded Warrants. This effectiveness removes the final regulatory barrier to the offering, which the company is pursuing amid a micro-cap market cap (~$3M), a 13% YoY revenue decline to $4.73M in FY2025, going concern risk, and a rapid transformation into digital assets and real estate development.
Key Facts
- Effectiveness date: September 28, 2026
- Registration statement (File No. 333-298442) declared effective under the 1933 Act
- Offering type: best-efforts of Class A Ordinary Shares and Pre-Funded Warrants with no minimum offering amount
- Company market cap ~$3M as of prior filing
- FY2025 revenue declined 13% YoY to $4.73M
- Net income of $9.73M driven by non-cash $21.65M bargain purchase gain; core operations had $10.73M operating loss
- Going concern risk noted in prior filing
- Seven reverse stock splits executed since February 2025
- Nasdaq compliance challenges ongoing
- $250K convertible note purchase agreement with Labrys Fund II, L.P. adds to debt burden
Financial Impact
Dilutive offering of undisclosed size; prior filing indicated no minimum offering amount. Company had $3M market cap, $10.73M operating loss, and $250K convertible note. Dilution could be substantial relative to current equity base.
Risk Factors
- Substantial dilution from the offering relative to current micro-cap equity base
- Going concern risk persists even after capital raise
- Nasdaq delisting risk from low bid price and reverse stock splits
- Core business revenue declining 13% YoY; transformation into digital assets adds execution risk
- Convertible note overhang from Labrys Fund II
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-003079 |
| Document: 9999999995-26-003079-index.html | 9999999995-26-003079 |
| Document: 9999999995-26-003079.txt | 9999999995-26-003079 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 6d ago | 6-K | $0.1884 $0.1489 | ▼ −20.97% | ▼ −19.79% | $1.15 (+510.40%) |
Oct 7, 2026 20d ago | 6-K | $0.0811 $0.0721 | ▲ +11.10% | ▲ +11.70% | $1.15 (−1318.00%) |
Oct 7, 2026 20d ago | 6-K | $0.1060 $0.0811 | ▼ −23.49% | ▼ −23.07% | $1.15 (+984.91%) |
Oct 6, 2026 21d ago | SC 13D/A | $0.0987 $0.1060 | ▲ +7.40% | ▲ +7.64% | $1.15 (+1065.15%) |
Oct 5, 2026 22d ago | 6-K | $0.1100 $0.0987 | ▲ +10.27% | ▲ +10.82% | $1.15 (−945.45%) |
Sep 30, 2026 27d ago | Press Release | $0.1680 $0.1010 | ▲ +39.88% | ▲ +40.06% | $1.15 (−584.52%) |
Sep 30, 2026 27d ago | 424B4 | $5.38 $3.23 | ▲ +39.88% | ▲ +40.06% | $1.15 (+78.61%) |
Sep 29, 2026 28d ago | EFFECT | $0.0720 $0.1680 | ▼ −133.33% | ▼ −133.54% | $1.15 (−1497.22%) |
Sep 28, 2026 28d ago | Press Release | $0.0720 $0.1680 | ▼ −133.33% | ▼ −133.54% | $1.15 (−1497.22%) |
Sep 2, 2026 7w ago | Insider Cluster | $1.21 $1.18 | ▼ −2.48% | ▼ −3.53% | $1.15 (−4.96%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers